Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort studyCarla Casulo, Matthew J. Maurer, Izidore S. Lossos et al.|The Lancet Haematology|2022Cited by 65
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study Reflects the Demographics and Subtypes of Patients Diagnosed with Non-Hodgkin Lymphoma in the United StatesChristopher R. Flowers, James R. Cerhan, Brian K. Link et al.|Blood|2018Cited by 9